142 related articles for article (PubMed ID: 16601282)
1. A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.
Ueda E; Ozerdem U; Chen YH; Yao M; Huang KT; Sun H; Martins-Green M; Bartolini P; Walker AM
Endocr Relat Cancer; 2006 Mar; 13(1):95-111. PubMed ID: 16601282
[TBL] [Abstract][Full Text] [Related]
2. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
[TBL] [Abstract][Full Text] [Related]
3. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
4. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells.
Jeong A; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Kim SH
Biol Pharm Bull; 2010; 33(6):945-50. PubMed ID: 20522957
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide: an endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo.
Koehl GE; Geissler EK; Iacobelli M; Frei C; Burger V; Haffner S; Holler E; Andreesen R; Schlitt HJ; Eissner G
Cancer Biol Ther; 2007 May; 6(5):686-90. PubMed ID: 17495522
[TBL] [Abstract][Full Text] [Related]
6. A molecular mimic of phosphorylated prolactin (S179D PRL) secreted by eukaryotic cells has a conformation with an increased positive surface charge compared to that of unmodified prolactin.
Ueda EK; Soares CR; Bartolini P; DeGuzman A; Lorenson MY; Walker AM
Biochemistry; 2009 Jul; 48(29):6887-97. PubMed ID: 19555049
[TBL] [Abstract][Full Text] [Related]
7. Common and specific effects of the two major forms of prolactin in the rat testis.
Williams VL; DeGuzman A; Dang H; Kawaminami M; Ho TW; Carter DG; Walker AM
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1795-803. PubMed ID: 17911340
[TBL] [Abstract][Full Text] [Related]
8. Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.
Liu JJ; Huang TS; Cheng WF; Lu FJ
Int J Cancer; 2003 Sep; 106(4):559-565. PubMed ID: 12845652
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
Schroeder MD; Brockman JL; Walker AM; Schuler LA
Endocrinology; 2003 Dec; 144(12):5300-7. PubMed ID: 12970160
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate.
Xu X; Wu W; Williams V; Khong A; Chen YH; Deng C; Walker AM
Prostate; 2003 Jan; 54(1):25-33. PubMed ID: 12481252
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
Kim MS; Lee YM; Moon EJ; Kim SE; Lee JJ; Kim KW
Int J Cancer; 2000 Jul; 87(2):269-75. PubMed ID: 10861486
[TBL] [Abstract][Full Text] [Related]
14. Both prolactin (PRL) and a molecular mimic of phosphorylated PRL, S179D-PRL, protect the hippocampus of female rats against excitotoxicity.
Morales T; Lorenson M; Walker AM; Ramos E
Neuroscience; 2014 Jan; 258():211-7. PubMed ID: 24252319
[TBL] [Abstract][Full Text] [Related]
15. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
Sulochana KN; Fan H; Jois S; Subramanian V; Sun F; Kini RM; Ge R
J Biol Chem; 2005 Jul; 280(30):27935-48. PubMed ID: 15923192
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of delayed type hypersensitivity response to Candida albicans produced by a molecular mimic of phosphorylated prolactin.
Guzmán EA; Chen YH; Langowski JL; De Guzman A; Lo HL; Walter B; Muller HK; Walker AM; Owen LB
J Neuroimmunol; 2005 Dec; 170(1-2):31-40. PubMed ID: 16169603
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
[TBL] [Abstract][Full Text] [Related]
18. Uncaria rhynchophylla induces angiogenesis in vitro and in vivo.
Choi DY; Huh JE; Lee JD; Cho EM; Baek YH; Yang HR; Cho YJ; Kim KI; Kim DY; Park DS
Biol Pharm Bull; 2005 Dec; 28(12):2248-52. PubMed ID: 16327159
[TBL] [Abstract][Full Text] [Related]
19. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland.
Kuo CB; Wu W; Xu X; Yang L; Chen C; Coss D; Birdsall B; Nasseri D; Walker AM
Cell Tissue Res; 2002 Sep; 309(3):429-37. PubMed ID: 12195299
[TBL] [Abstract][Full Text] [Related]
20. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
